Most Read Articles
6 days ago
Among patients with rheumatoid arthritis, those who are obese are more likely to have worse disease activity, lower functional ability and poorer health-related quality of life compared with their nonobese counterparts, a study has found.
30 May 2016
Good glycaemic control and minimizing CV risk factors are the cornerstones of T2D management. Empagliflozin, a SGLT2 inhibitor, has a unique mechanism of action that not only lowers plasma glucose but also other CV risk factors. The EMPA-REG OUTCOME® trial explored the CV benefits of this drug, and a panel of eminent speakers gathered recently to present the implications of this study and empagliflozin on clinical practice.
17 May 2017
The high-concentration capsaicin patch shows promise in the management of painful diabetic peripheral neuropathy (PDPN), with an effect that is similar to that observed with oral agents but offering systemic tolerability benefits, according to a network meta-analysis.

Endocrine disruptors culprits in declining sperm quality

02 Jun 2017

Endocrine disruptors, which can be found in plastics, pesticides and receipts from thermal printers, have been linked to declining sperm quality in adults, says an expert.

Speaking in an interview with MIMS Doctor, Professor Dr. Mustafa Ali Mohd of the Faculty of Medicine, University of Malaya, said scientists have observed a steady decline in sperm quality since as early as the 1990s and the drop in sperm quality was associated with exposure to endocrine disrupting chemicals (EDCs). Around the year 2000, scientists discovered plastics contained EDCs that were contributors of endocrine related conditions such as reduced sperm quality, obesity and diabetes.

Endocrine disruptors affect some receptors of the endocrine system by making it unresponsive, act negatively or give unexpected effects, explained Mustafa. Plastics contain an EDC known as phthalates, which is the most abundantly produced plasticizer—a substance, typically a solvent added to a synthetic resin to produce or promote plasticity—and has been associated with testicular dysgenesis syndrome. [Trends Endocrinol Metab 2009;20(3):139–145] Moreover, a recent study showed that phthalate exposure in early pregnancy is associated with a higher prevalence of male genital abnormalities in the newborns. [J Clin Endocrinol Metab 2017. Doi: 10.1210/jc.2016-3837]

There are various local studies available on the exposure to EDC. Among the findings was the presence of many types of EDC in drinking water and high levels of various EDCs in the river water in certain parts of the country, said Mustafa. [J Water Health 2013;11(2):311–323, Clean Soil Air Water 2015;43:804–810] Malaysians are frequently exposed to EDCs from domestic plastic materials such as plates, cups, containers and cooking wares. Worryingly, EDCs have been detected in breast milk and cord blood of newborns as well, said Mustafa. 

The quality of sperm is on the decline, with reported reduction in semen volume, sperm concentration, sperm forward motility and total sperm count. At the same time, the incidence of reproductive disorders such as testicular cancer is on the rise. [BMJ 1992;305(6854):609–613, Asian J Androl 2016. Doi:10.4103/1008-682X.179533, Reprod Med Biol 2007;6:185]

At the moment, the exact cause and mechanism behind the declining trend in sperm quality is still being studied. Regardless of the cause of the decline, sperm quality is a vital factor in determining fertility and it will be wise to avoid materials that contain endocrine disruptors, advised Mustafa.

Endocrine disruptors are chemicals that have adverse effects on the endocrine system, leading to disrupted developmental, neurological, reproductive and immune systems. [National Institute of Environmental Health Sciences. Available at: https://www.niehs.nih.gov/health/topics/agents/endocrine/. Last accessed 3rd April] 

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago
Among patients with rheumatoid arthritis, those who are obese are more likely to have worse disease activity, lower functional ability and poorer health-related quality of life compared with their nonobese counterparts, a study has found.
30 May 2016
Good glycaemic control and minimizing CV risk factors are the cornerstones of T2D management. Empagliflozin, a SGLT2 inhibitor, has a unique mechanism of action that not only lowers plasma glucose but also other CV risk factors. The EMPA-REG OUTCOME® trial explored the CV benefits of this drug, and a panel of eminent speakers gathered recently to present the implications of this study and empagliflozin on clinical practice.
17 May 2017
The high-concentration capsaicin patch shows promise in the management of painful diabetic peripheral neuropathy (PDPN), with an effect that is similar to that observed with oral agents but offering systemic tolerability benefits, according to a network meta-analysis.